Mr Lawrence Gozlan has 20 years of experience as a leading biotechnology investor and corporate advisor with deep roots in the scientific community. He is the Chief Investment Officer and Founder of Scientia Capital, a specialised global investment fund focused exclusively on life sciences. The Company was founded to provide high level expertise and manage investments for high-net-worth individuals, family offices and institutional investors wanting exposure to the biotechnology industry.
Prior to this, Lawrence managed the largest biotechnology investment fund in Australia at QIC (“the Queensland Investment Corporation”), an investment fund with over AU$60 billion under management. Earlier in his career, he worked as the senior biotechnology analyst in the equities team at Foster Stockbroking, and gained senior corporate finance experience advising life sciences companies at Deloitte.
He currently serves as a director on several private and public company boards in Australia and the US. Lawrence holds a Bachelor of Science with Honours from the University of Melbourne.
| Position | Non-Executive Director and Chair of the Audit and Risk Committee |
|---|---|
| Speciality | Biotechnology Investment |
| Qualifications & Professional Memberships |
|
| Areas of Expertise |
|
Ceryvyn Therapeutics Limited ABN 32 006 340 567.
An Australian biotechnology company (ASX: CYV) developing a biologic therapy for the rare disease LAM
(lymphangioleiomyomatosis).
Subscribe to Updates
© 2026 Ceryvyn Therapeutics All rights reserved